These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36278424)

  • 1. Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH).
    Weißert K; Ammann S; Kögl T; Dettmer-Monaco V; Schell C; Cathomen T; Ehl S; Aichele P
    EMBO Mol Med; 2022 Dec; 14(12):e16085. PubMed ID: 36278424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis.
    Dettmer-Monaco V; Weißert K; Ammann S; Monaco G; Lei L; Gräßel L; Rhiel M; Rositzka J; Kaufmann MM; Geiger K; Andrieux G; Lao J; Thoulass G; Schell C; Boerries M; Illert AL; Cornu TI; Ehl S; Aichele P; Cathomen T
    J Allergy Clin Immunol; 2024 Jan; 153(1):243-255.e14. PubMed ID: 37595758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations.
    Ghosh S; Carmo M; Calero-Garcia M; Ricciardelli I; Bustamante Ogando JC; Blundell MP; Schambach A; Ashton-Rickardt PG; Booth C; Ehl S; Lehmberg K; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2018 Sep; 142(3):904-913.e3. PubMed ID: 29355678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Versus Cytokine - Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity.
    Wegehaupt O; Wustrau K; Lehmberg K; Ehl S
    Front Immunol; 2020; 11():808. PubMed ID: 32457750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Updates on Classification, Diagnosis and Treatment of Hemophagocytic Lymphohistiocytosis (HLH).
    Madkaikar M; Shabrish S; Desai M
    Indian J Pediatr; 2016 May; 83(5):434-43. PubMed ID: 26872683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
    J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis-like hyperinflammation and enhanced myelopoiesis.
    Tang Y; Xu Q; Luo H; Yan X; Wang G; Hu L; Jin J; Witte DP; Marsh RA; Huang L; Huang G; Zhou J
    J Allergy Clin Immunol; 2022 Nov; 150(5):1154-1167. PubMed ID: 35792218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management.
    Morimoto A; Nakazawa Y; Ishii E
    Pediatr Int; 2016 Sep; 58(9):817-25. PubMed ID: 27289085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
    Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
    J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease.
    Kögl T; Müller J; Jessen B; Schmitt-Graeff A; Janka G; Ehl S; zur Stadt U; Aichele P
    Blood; 2013 Jan; 121(4):604-13. PubMed ID: 23190531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children.
    Xu XJ; Tang YM
    World J Pediatr; 2020 Aug; 16(4):333-340. PubMed ID: 31506890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
    Hines MR; Knight TE; McNerney KO; Leick MB; Jain T; Ahmed S; Frigault MJ; Hill JA; Jain MD; Johnson WT; Lin Y; Mahadeo KM; Maron GM; Marsh RA; Neelapu SS; Nikiforow S; Ombrello AK; Shah NN; Talleur AC; Turicek D; Vatsayan A; Wong SW; Maus MV; Komanduri KV; Berliner N; Henter JI; Perales MA; Frey NV; Teachey DT; Frank MJ; Shah NN
    Transplant Cell Ther; 2023 Jul; 29(7):438.e1-438.e16. PubMed ID: 36906275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic lymphohistiocytosis: when the immune system runs amok.
    Janka G
    Klin Padiatr; 2009 Sep; 221(5):278-85. PubMed ID: 19707989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial and acquired hemophagocytic lymphohistiocytosis.
    Janka G; zur Stadt U
    Hematology Am Soc Hematol Educ Program; 2005; ():82-8. PubMed ID: 16304363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.
    La Rosée P; Horne A; Hines M; von Bahr Greenwood T; Machowicz R; Berliner N; Birndt S; Gil-Herrera J; Girschikofsky M; Jordan MB; Kumar A; van Laar JAM; Lachmann G; Nichols KE; Ramanan AV; Wang Y; Wang Z; Janka G; Henter JI
    Blood; 2019 Jun; 133(23):2465-2477. PubMed ID: 30992265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome.
    Jessen B; Maul-Pavicic A; Ufheil H; Vraetz T; Enders A; Lehmberg K; Längler A; Gross-Wieltsch U; Bay A; Kaya Z; Bryceson YT; Koscielniak E; Badawy S; Davies G; Hufnagel M; Schmitt-Graeff A; Aichele P; Zur Stadt U; Schwarz K; Ehl S
    Blood; 2011 Oct; 118(17):4620-9. PubMed ID: 21878672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophagocytic syndromes--an update.
    Janka GE; Lehmberg K
    Blood Rev; 2014 Jul; 28(4):135-42. PubMed ID: 24792320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation.
    Landy E; Varghese J; Dang V; Szymczak-Workman A; Kane LP; Canna SW
    Blood Adv; 2023 Nov; 7(22):6949-6963. PubMed ID: 37738167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire.
    Ammann S; Lehmberg K; Zur Stadt U; Janka G; Rensing-Ehl A; Klemann C; Heeg M; Bode S; Fuchs I; Ehl S;
    Eur J Immunol; 2017 Feb; 47(2):364-373. PubMed ID: 27925643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
    El-Mallawany NK; Curry CV; Allen CE
    Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.